JD Health International Inc.
JDHIF
$6.15
-$0.34-5.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.69% | 22.89% | 13.28% | 14.18% | 1.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.69% | 22.89% | 13.28% | 14.18% | 1.17% |
| Cost of Revenue | 22.14% | 20.38% | 12.22% | 13.12% | 0.17% |
| Gross Profit | 32.91% | 31.00% | 17.15% | 18.08% | 4.52% |
| SG&A Expenses | 20.27% | 18.53% | 9.73% | 10.61% | 3.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.61% | 19.86% | 11.74% | 12.63% | 0.74% |
| Operating Income | 105.81% | 102.84% | 151.68% | 152.09% | 13.91% |
| Income Before Tax | 17.57% | 15.87% | 174.45% | 176.64% | 28.90% |
| Income Tax Expenses | -32.66% | -33.63% | -16.24% | -15.57% | 45.55% |
| Earnings from Continuing Operations | 27.56% | 25.73% | 266.77% | 269.70% | 26.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.08% | 79.42% | 602.86% | 605.36% | 528.32% |
| Net Income | 27.64% | 25.80% | 267.38% | 270.31% | 26.25% |
| EBIT | 105.81% | 102.84% | 151.68% | 152.09% | 13.91% |
| EBITDA | 97.74% | 94.89% | 192.21% | 192.95% | 11.57% |
| EPS Basic | 26.79% | 25.00% | 264.34% | 268.75% | 25.49% |
| Normalized Basic EPS | 16.96% | 15.04% | 173.95% | 175.63% | 28.24% |
| EPS Diluted | 25.00% | 23.23% | 261.24% | 265.63% | 28.00% |
| Normalized Diluted EPS | 16.47% | 14.84% | 174.58% | 178.63% | 29.46% |
| Average Basic Shares Outstanding | 0.65% | 0.65% | 0.59% | 0.59% | 0.63% |
| Average Diluted Shares Outstanding | 1.08% | 1.08% | -0.02% | -0.02% | -0.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |